Designed around specialist workflows
A liquid-biopsy research programme focused on circulating tumour DNA analysis and longitudinal biomarker research.
Intended audiences
Translational oncology and qualified laboratory teams.
A liquid-biopsy research programme focused on circulating tumour DNA analysis and longitudinal biomarker research.

A liquid-biopsy research programme focused on circulating tumour DNA analysis and longitudinal biomarker research.
Translational oncology and qualified laboratory teams.
Development-stage concept. The features described are proposed and may change. No autonomous diagnosis, regulatory clearance, clinical performance, product availability or active clinical trial is claimed.
Start a conversation with the SCILabel team.
Your email lets our team send you a reply if you leave the website.